Clinical Trial

Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm

Study acronym: VORIPRECI
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this interventional single-arm study is to evaluate the interest of a multiparametric algorithm for individualization of first voriconazole maintenance doses for improvement of initial voriconazole exposure in adult patients with haematological malignancies. The main objective it aims is to determine the percentage of patients with initial voriconazole trough concentrations in the therapeutic range after individualization of first maintenance doses. Participants will benefited from individualization of first voriconazole maintenance doses through a previously developed and validated multiparametric algorithm (publication in progress) taking into account CYP2C19 genotype, C reactive protein level and age.
Trial Details
NCT Number NCT06582186
Lead Sponsor University Hospital, Grenoble
Conditions Aspergillosis Invasive, Fungal Infection, Hematologic Malignancy
Enrollment 30 participants
Start Date 2024-10
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-03